CX3CL1 and liver disorder: During fibrosis amelioration, MSCs can participate in Ly-6C-high (inflammatory) to Ly-6C low (anti-inflammatory) macrophage polarization by increasing CX3CL1 levels, exerting significant effects on ameliorating liver disease [35].